MENU
PILL
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for PILL with price predictions
Nov 04, 2026

Momentum Indicator for PILL turns positive, indicating new upward trend

PILL saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 78 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PILL's RSI Oscillator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for PILL just turned positive on October 20, 2026. Looking at past instances where PILL's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.

Following a +7.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in 286 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

PILL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 59 of 64 cases where PILL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PILL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF is 54.59B. The market cap for tickers in the group ranges from 34.05M to 1.26T. LLY holds the highest valuation in this group at 1.26T. The lowest valued company is EYPT at 34.05M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 22%. For the same ETF, the average monthly price growth was 72%, and the average quarterly price growth was 101%. RLMD experienced the highest price growth at 24%, while CRMD experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 52%. For the same stocks of the ETF, the average monthly volume growth was 14% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 52
Price Growth Rating: 50
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 11 (-100 ... +100)
Momentum Indicator for PILL turns positive, indicating new upward trend